Download Free Pharmacopolitics Book in PDF and EPUB Free Download. You can read online Pharmacopolitics and write the review.

Pharmacopolitics: Drug Regulation in the United States and Germany
This revised and extended second edition focuses on current and emerging topics in drug development, their molecular mechanisms of action as well as regulatory issues. In addition, in-depth insights into clinical drug research and trial methodology are presented on the basis of concrete case studies. This updated book makes a valuable contribution to the field of Clinical Pharmacology and serves as a must-have guide for professors, researchers and advanced students from academia and pharmaceutical industry.
The SAGE Encyclopedia of Pharmacology and Society explores the social and policy sides of the pharmaceutical industry and its pervasive influence in society. While many technical STM works explore the chemistry and biology of pharmacology and an equally large number of clinically oriented works focus on use of illegal drugs, substance abuse, and treatment, there is virtually nothing on the immensely huge business (“Big Pharma”) of creating, selling, consuming, and regulating legal drugs. With this new Encyclopedia, the topic of socioeconomic, business and consumer, and legal and ethical issues of the pharmaceutical industry in contemporary society around the world are addressed. Key Features: 800 signed articles, authored by prominent scholars, are arranged A-to-Z and published in a choice of electronic or print formats Although arranged A-to-Z, a Reader's Guide in the front matter groups articles by thematic areas Front matter also includes a Chronology highlighting significant developments in this field All articles conclude with Further Readings and Cross References to related articles Back matter includes an annotated Resource Guide to further research, a Glossary, Appendices (e.g., statistics on the amount and types of drugs prescribed, etc.), and a detailed Index The Index, Reader’s Guide, and Cross References combine for search-and-browse capabilities in the electronic edition The SAGE Encyclopedia of Pharmacology and Society is an authoritative and rigorous source addressing the pharmacology industry and how it influences society, making it a must-have reference for all academic libraries as a source for both students and researchers to utilize.
The Pharmaceutical Studies Reader is an engaging survey of the field that brings together provocative, multi-disciplinary scholarship examining the interplay of medical science, clinical practice, consumerism, and the healthcare marketplace. Draws on anthropological, historical, and sociological approaches to explore the social life of pharmaceuticals with special emphasis on their production, circulation, and consumption Covers topics such as the role of drugs in shaping taxonomies of disease, the evolution of prescribing habits, ethical dimensions of pharmaceuticals, clinical trials, and drug research and marketing in the age of globalization Offers a compelling, contextually-rich treatment of the topic that exposes readers to a variety of approaches, ideas, and frameworks Provides an accessible introduction for readers with no previous background in this area
In recent years medicalization, the process of making something medical, has gained considerable ground and a position in everyday discourse. In this multidisciplinary collection of original essays, the authors expertly consider how issues around medicalization have developed, ways in which it is changing, and the potential shapes it will take in the future. They develop a unique argument that medicalization, biomedicalization, pharmaceuticalization and geneticization are related and co-evolving processes, present throughout the globe. This is an ideal addition to anthropology, sociology and STS courses about medicine and health.
One of the most striking features of the twentieth century has been the rapid growth of the pharmaceutical industry and the large increases in the use and consumption of its products. This trend began in the first half of the century, but accelerated most sharply after the Second World War, when the creation of national systems of healthcare created mass markets for drugs. The industry then assumed a major economic, social and political significance, and became one of the most highly regulated sectors of the economy, attracting the attention of industry analysts as well as academics. This volume brings together a collection of papers exploring and reflecting upon some of the significant strands in the current studies of pharmaceuticals in the twentieth century. They touch upon many of the issues that are matters of concern and debate today, and their international and multidisciplinary approaches enrich our understanding of an object, of an industry, and of a process that are at the heart of our highly medicalized contemporary societies.
This book provides an overview of the global pharmaceutical pricing policies. Medicines use is increasing globally with the increase in resistant microbes, emergence of new treatments, and because of awareness among consumers. This has resulted in increased drug expenditures globally. As the pharmaceutical market is expanding, a variety of pharmaceutical pricing strategies and policies have been employed by drug companies, state organizations and pharmaceutical pricing authorities.
'The very last thing a drug regulator wishes to be able to say is, like Lord Byron (1788-1824), on the publication of his poem Childe Harold's Pilgrimage, 'I awoke one morning and found myself famous.' The twelfth edition of this long-established textbook of clinical pharmacology (first published in 1960) continues its fine tradition of balancing science and practice for improved evidence-based drug therapy and good prescribing in therapeutic settings increasingly complicated by intercurrent disease and polypharmacy. - Coverage of all major therapeutic topics by body system. - Introductory sections give brief chapter synopses. - Case studies where relevant. - Covers the needs of the developing world with a focus on practical prescribing and health technology assessment. - Definition, tips, brief explanation boxes throughout. - Interesting histories, etymologies and provenances of terms throughout. - Entertaining footnotes throughout. - Fully updated throughout. - New co-editor: Fraz Mir, Addenbrooke's Hospital and Department of Medicine, University of Cambridge. - Now with free e-book on StudentConsult.
Equitable Access to High-Cost Pharmaceuticals seeks to aid the development and implementation of equitable public health policies by pharmaco-economics professionals, health economists, and policymakers. With detailed country-by country analysis of policy and regulation, the Work compares and contrasts national healthcare systems to support researchers and practitioners identify optimal healthcare policy solutions. The Work incorporates chapters on global regulatory changes, health technology assessment guidelines, and competitive effectiveness research recommendations from international bodies such as the OECD or the EU. Novel policies such as horizon scanning, managed-entry agreement and post-launch monitoring are considered in detail. The Work also thoroughly reviews novel pharmaceuticals with particular research interest, including cancer drugs, orphan medicines, Hep C, and personalized medicines. - Evaluates impact and efficacy of current access policies and pricing regulation of high-cost drugs - Incorporates existing guidelines and recommendations by international organizations - Compares and contrasts how different countries fund and police high-cost drug access - Explores novel and emergent policies, including managed entry agreement, analysis of real world data and differential pricing - Reviews novel pharmaceuticals of current research interest